Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5

Author:

Chen Jenny X.1,Krane Markus1,Deutsch Marcus-Andre1,Wang Li1,Rav-Acha Moshe1,Gregoire Serge1,Engels Marc C.1,Rajarajan Kuppusamy1,Karra Ravi1,Abel E. Dale1,Wu Joe C.1,Milan David1,Wu Sean M.1

Affiliation:

1. From the Cardiovascular Research Center, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA (J.X.C., M.K., M.A.D., M.R.-A., S.G., M.C.E., K.R., D.M., S.M.W.); German Heart Center Munich, Department of Cardiovascular Surgery, Department of Experimental Surgery, Technische Universität München, Munich, Germany (M.K., M.A.D.); Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA (L.W., J.C.W.); Division...

Abstract

Rationale: Direct reprogramming of fibroblasts into cardiomyocytes is a novel strategy for cardiac regeneration. However, the key determinants involved in this process are unknown. Objective: To assess the efficiency of direct fibroblast reprogramming via viral overexpression of GATA4, Mef2c, and Tbx5 (GMT). Methods and Results: We induced GMT overexpression in murine tail tip fibroblasts (TTFs) and cardiac fibroblasts (CFs) from multiple lines of transgenic mice carrying different cardiomyocyte lineage reporters. We found that the induction of GMT overexpression in TTFs and CFs is inefficient at inducing molecular and electrophysiological phenotypes of mature cardiomyocytes. In addition, transplantation of GMT infected CFs into injured mouse hearts resulted in decreased cell survival with minimal induction of cardiomyocyte genes. Conclusions: Significant challenges remain in our ability to convert fibroblasts into cardiomyocyte-like cells and a greater understanding of cardiovascular epigenetics is needed to increase the translational potential of this strategy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Cited by 215 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Direct Cardiac Reprogramming in the Age of Computational Biology;Journal of Cardiovascular Development and Disease;2024-09-04

2. Transcriptional Factors Mediated Reprogramming to Pluripotency;Current Stem Cell Research & Therapy;2024-04

3. Next-generation direct reprogramming;Frontiers in Cell and Developmental Biology;2024-02-02

4. Current Developments of Electroconductive Scaffolds for Cardiac Tissue Engineering;Handbook of Stem Cell Applications;2024

5. A novel transcription factor combination for direct reprogramming to a spontaneously contracting human cardiomyocyte-like state;Journal of Molecular and Cellular Cardiology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3